Balsalazide and azathioprine or 6-mercaptopurine.
Green
J R
JR
D000284:Administration, Oral; D000636:Aminosalicylic Acids / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics / Q000494:pharmacology*; D000963:Antimetabolites / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D001379:Azathioprine / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000494:pharmacology; D004347:Drug Interactions; D006801:Humans; D020128:Inhibitory Concentration 50; D015122:Mercaptopurine / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000494:pharmacology; D019804:Mesalamine; D008780:Methyltransferases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D010659:Phenylhydrazines; D011355:Prodrugs / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*
D000636:Aminosalicylic Acids; D000963:Antimetabolites; D010659:Phenylhydrazines; D011355:Prodrugs; D019804:Mesalamine; D015122:Mercaptopurine; D008780:Methyltransferases; C022745:thiopurine methyltransferase; D001379:Azathioprine; C038637:balsalazide